Two Medicinal Chemistry Stories: (i) targeting MERTK for imaging in neurodegenerative disease; (ii) anticancer therapeutics targeting KAT6A
发布时间:2024-06-20   访问次数:10

607SKLBE学术论坛

Jonathan Baell, Executive Director of Discovery Chemistry at Lyterian Therapeutics

报告题目Two Medicinal Chemistry Stories: (i) targeting MERTK for imaging in neurodegenerative disease; (ii) anticancer therapeutics targeting KAT6A

报告时间2024-6-27(周四)1000

报告地点:实验18315会议室

:张立新教授


 
Baidu
sogou